Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study - Dimitrakopoulos, Foteinos-Ioannis; Mountzios, Giannis; Christopoulos, Petros; Papastergiou, Thomas; Elshiaty, Mariam; Daniello, Lea; Zervas, Elefterios; Agelaki, Sofia; Samantas, Epaminondas; Nikolaidi, Adamantia; Athanasiadis, Ilias; Baka, Sofia; et al. (Therapeutic advances in medical oncology, 2022)
Gesehen am 07.11.2022